Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot double-blind randomized placebo-controlled repeated-dose study of HPH116 in treatment-naïve HIV-1 patients
2007-000950-30Phase 2Active
- Sponsor
- H-PHAR,sa
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Human immunodeficiency virus infection type 1 comparing HPH116 (azodicarbonamide) with Placebo (2 arms). Primary endpoints: Safety and tolerability and Antiviral efficacy. Started Jun 2007; status: active.
02
Drugs
azodicarbonamide
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2007-000950-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000950-30.